Skip Navigation Links.
Activity Information
Study
Summary
Expert Perpective
References
Finish

Online CME Activity

Interaction and Outcomes of Clopidogrel and PPI in Patients Post-ACS


NOTE: Although this activity is no longer certified for credit, we believe that it contains important information and hope you’ll review, print or email it to a colleague.

Title:
Interaction and Outcomes of Clopidogrel and PPI in Patients Post-ACS
Release Date:
04/28/2009
Expiration Date:
04/28/2010
Topics:
Acute Coronary Syndrome
Primary Audience:
Cardiologists
Activity Format:
Expert Perspective
Credits:
1.00 AMA PRA Category 1 Credits™

 
Overall Satisfaction Rating:
Full Star Full Star Full Star Full Star Empty Star 80%

Learning Objectives

To describe the potential effects of the combination of clopidogrel plus a proton pump inhibitor (PPI) on morbidity and mortality outcomes in patients post acute coronary syndromes (ACS).

Accreditation

Essential Areas and Policies, including the 2004 Updated Standards for Commercial Support. Pri-Med faculty hail from a variety of institutions and participate in content development, along with Pri-Med Institute's Advisory Boards and its expert review partners, the University of Wisconsin School of Medicine and Public Health and Tufts Health Care Institute. All final decisions about program content are the responsibility of Pri-Med Institute.

Credits Type Accreditation Statement Designation Statement
1.00 AMA PRA Category 1 Credits™ Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Pri-Med Institute designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Faculty and Editorial Board

Written By: Marc Cohen, MD, FACC, (Read Bio), Chief of the Division of Cardiology, Director of the Cardiology Fellowship Training, Newark Beth Israel Medical Center, Newark, New Jersey; Professor of Medicine, Mount Sinai School of Medicine, New York, New York

Edited By: Monica Zangwill, MD, MPH

Financial Disclosure Statement(s)

Dr Cohen receives honoraria from sanofi-aventis U.S. and Bristol-Myers Squibb/Schering-Plough Partnership.

Dr Zangwill has no financial relationships to disclose.

The content collaborators at Academy for Healthcare Education, Inc. have no financial relationships to disclose.

Education Partner:

Academy for Healthcare Education

Commercial Support:

Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership

Instructions for Obtaining Credit:

Complete this activity. Answer the questions in the attached posttest and evaluation. Click on "claim credit" and follow the instructions to print out the credit certificate.

Computer System Requirements:

Internet Explorer (version 5.5 and above) is the recommended browser for Pri-Med Online eCME activities. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A minimum screen resolution setting of 800 x 600 is recommended. A high-speed Internet connection (DSL, cable modem, or LAN-based) is not required; however, it is recommended for faster download times.

Disclaimer

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, or M|C Communications, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.